Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find Clinical Trials & Studies

RESTORE Study

I'm Interested!

RESTORE – A prospective Randomized Control Trial to compare the efficacy of the Revi System Therapy on versus off in relieving urinary urge incontinence episodes

  • Sex: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Device
  • Trial Phase: NA
  • Conditions Being Studied:

Study Purpose

The purpose of this research study is to evaluate the effectiveness of the Revi System therapy in the treatment of urinary urge incontinence. Revi is a small FDA-approved device implanted near the ankle that stimulates the tibial nerve, which can help calm the bladder.

Who Can Participate

Individuals who suffer from symptoms of urgency incontinence alone or in combination with urinary urgency and are 18 years of age or older may meet the requirements for participation in this study.

Principal Investigator
Adonis Hijaz MD
Department/Division
Urology (Female Pelvic Medicine and Reconstructive Surgery)

Locations

UH Geauga Medical Center
13207 Ravenna Road
Chardon OH, 44024

UH Portage Medical Center
6847 North Chestnut Street
Ravenna Ohio, 44266

UH Ahuja Medical Center
3999 Richmond Road
Beachwood OH, 44122

UH Beachwood Medical Center
25501 Chagrin Blvd.
Beachwood OH, 44122

UH St. John Medical Center
29000 Center Ridge Road
Westlake OH, 44145

  • UH IRB: SITE00002166
  • StudyID: 2023-01380
  • ClinicalTrials.gov: NCT06217328
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422